Citadel Advisors
STIM icon

Citadel Advisors’s Neuronetics STIM Stock Holding History

Citadel Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6K Buy
+12,800
New +$18.6K ﹤0.01% 13437
2026
Q1 		– Sell
-52,500
Closed -$72.5K – 14182
2025
Q4 		$72.5K Buy
52,500
+22,700
+76% +$47.5K ﹤0.01% 11855
2025
Q3 		$81.4K Buy
29,800
+8,800
+42% +$31.3K ﹤0.01% 11963
2025
Q2 		$73.3K Sell
21,000
-6,500
-24% -$25.7K ﹤0.01% 11555
2025
Q1 		$101K Buy
27,500
+3,400
+14% +$12.4K ﹤0.01% 11441
2024
Q4 		$38.8K Sell
24,100
-6,000
-20% -$6.24K ﹤0.01% 12637
2024
Q3 		$22.9K Buy
+30,100
New +$39.5K ﹤0.01% 12679
2024
Q2 		– Sell
-200
Closed -$952 – 15355
2024
Q1 		$952 Buy
+200
New +$703 ﹤0.01% 14213
2023
Q4 		– Sell
-600
Closed -$810 – 15210
2023
Q3 		$810 Buy
600
+200
+50% +$350 ﹤0.01% 13976
2023
Q2 		$860 Sell
400
-3,400
-89% -$8.25K ﹤0.01% 14036
2023
Q1 		$11.1K Sell
3,800
-2,600
-41% -$13.1K ﹤0.01% 13490
2022
Q4 		$44K Buy
+6,400
New +$30.2K ﹤0.01% 12288
2021
Q4 		– Sell
-24,000
Closed -$157K – 14720
2021
Q3 		$157K Buy
24,000
+5,800
+32% +$55.6K ﹤0.01% 12324
2021
Q2 		$292K Sell
18,200
-1,700
-9% -$23.5K ﹤0.01% 11336
2021
Q1 		$246K Buy
+19,900
New +$305K ﹤0.01% 11273

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors's STIM Position: Q2 2026 in Review

Citadel Advisors increased its Neuronetics (STIM) stake by 451% in Q2 2026, buying an estimated $502K and bringing the position to 421,903 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #9624.

Citadel Advisors first reported a position in STIM in Q2 2018 and has held it in 25 quarters since. The position peaked at $1.03M in Q1 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Citadel Advisors held 421,903 shares of Neuronetics worth $548K as of Q2 2026.
  • Citadel Advisors bought 345,306 Neuronetics shares in Q2 2026, an estimated $502K.
  • Neuronetics made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9624 holding.
  • Citadel Advisors first reported a position in Neuronetics in Q2 2018 and has held it in 25 quarters since.
  • Citadel Advisors's Neuronetics position peaked at $1.03M in Q1 2021.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.